syndrome can lead to elevated inflammatory markers in its own right, flares of CPPD arthropathy may be triggered by systemic infection. We consider this to have been the case in this patient with a probable urinary tract infection. Key learning points: 1) CPPD deposition of the odontoid peg (crowned dens syndrome) is characterised by atraumatic episodes of cervical pain and stiffness, particularly on rotation, and can be misdiagnosed as fracture, local or meningeal infection, and neoplasm. 2) Plain film appearances can often suggest the diagnosis of crowned dens syndrome, although further imaging is usually required exclude important differential diagnoses. The identification of calcification, for example of the dens or the transverse and alar ligaments, on computed tomography is a typical finding. 3) Early recognition of the clinical features of crowned dens syndrome can prevent over-investigation, for example with lumbar puncture orbiopsy,as wellas over-treatmentforsuspected bacterial orviral central nervous system, or musculoskeletal infections. 4) Treatment of crowned dens syndrome is usually with non-steroidal anti-inflammatories unless contraindicated, and our experience suggests that topical therapy can be effective. Successful treatment has also been reported with colchicine and corticosteroids.
Introduction: McCarty et al first described the Milwaukee shoulder in 1981 after encountering four elderly women with similar patterns of destructive shoulder arthropathy, rotator cuff loss and large recurrent joint effusions containing basic calcium phosphate crystals. A variety of descriptive terms have since been adopted including apatite-associated destructive arthritis and idiopathic destructive arthritis of the shoulder and although it does most commonly affect the shoulders, it can affect any large joint. Knee disease predominantly involves the patellofemoral and lateral tibiofemoral compartments and results in valgus deformity as described by the McCarty group in 1986.2 A few years later, in 1990, reports for a total of 72 patients with the Milwaukee Shoulder Syndrome were amalgamated and comprise the largest dataset to date for this condition.3-7 Women were predominantly affected with a ratio of 4:1 and a mean age at onset of 72 years. Both shoulders were affected in 64% of patients and nearly a third had experienced trauma or joint overuse preceding the symptoms. From these historical reports we now know that patients typically present with an insidious onset (over months or years) of joint swelling associated with pain and restriction of movement. Examination reveals large shoulder effusions, often extending to the subdeltoid region, reduced active range of movement and pronounced joint instability which reflects the radiographic findings in this condition. There is characteristically superior subluxation of the humeral head, sometimes forming a pseudoarthrosis with the distal clavicle and acromion which is only possible due to widespread rotator cuff loss. Aspirated synovial fluid is typically haemorrhagic, non-inflammatory and can be positive for calcium apatite crystals. Treatment is largely supportive and oral antiinflammatories and intra-articular corticosteroid injections can provide symptomatic relief. Its natural history remains unclear but cases seem to stabilise after 1-2 years with reduction of symptoms, joint effusions and radiographic progression.8 Case description: A 73-year-old lady presented initially to the Acute Medical Unit with a 6-month history of generalised joint pain and 3-stone weight loss following her husband's death. She used to be her husband's carer and 6 months prior to presenting to us she suffered a traumatic fall onto her right side when her husband fell onto her. A month after the fall she presented to A&E with right hip pain, she underwent hip and chest radiography and was reassured there was no fracture. However when the plain films were reviewed after discharge anterior subluxation of the right shoulder was noted and the patient was recalled urgently for assessment. By the time she presented to us, although she complained of widespread arthralgia affecting the hips, knees and right ankle, the worst joints were certainly the shoulders. Here she described quite longstanding symptoms (for at least 3 years) of pain and restriction of movement (right worse than left) with associated joint swelling. She had been furniture walking for the last monthand this may indicate some overuse of both shoulder joints. On examination she was very frail and there were bilateral cool shoulder effusions (right larger than left) with significant restriction of movement. All other joints were unremarkable. We proceeded to aspirate the right shoulder and obtained 30ml of haemorrhagic non-inflammatory synovial fluid; no crystals were seen on polarised microscopy and cultures proved negative. Alizarin red staining was not undertaken. A malignancy screen was also done and was unremarkable. Plain films showed chronic significant bilateral anterior dislocation of the humeral heads indicative of severe rotator cuff destruction. There was also marked soft tissue swelling and calcification. Milwaukee shoulder syndrome was diagnosed and intra-articular corticosteroid injection provided for symptomatic relief. We will follow-up with the patient in due course and consider if further imaging and orthopaedic input are appropriate given both her frailty and the fact that shoulder prostheses tend not to be successful in joints where the rotatorcuff hasbeen lost. Discussion: Milwaukee shoulder is a rare arthropathy characterised by the presence of intra-articular or peri-articular hydroxyapatite crystals and rapid rotator cuff as well as glenohumeral joint destruction. It differs from osteoarthritis given the widespread loss of cartilage, marked softening of the humeral head and presence of relatively small osteophytes; whereas osteoarthritis here is characterised by sclerosis of the humeral head, prominent osteophytes and an intact rotator cuff. It is also important to note that although our patient presented with pain and restriction of movement, the Milwaukee shoulder can often be painless and the joint deformity tends to be far worse than the degree of pain experiencedalmost as if it were a Charcot joint (but with no evidence of neurological impairment). Alizarin red staining, although not used in our patient, is a simple and quick screening method to identify microcrystalline or noncrystalline calcium phosphate salts in synovial fluid. A historical study9 showed that this technique can pick up crystals missed by polarised light. Treatment, as mentioned above, is currently supportive and the focus is on symptomatic relief. Physiotherapy plays a major role in keeping the joint mobile and strengthening the surrounding muscles. Drug therapies such as non-steroidal anti-inflammatory drugs and intra-articular corticosteroids are widely used with varying degrees of benefit. Phosphacitrate has been shown to reduce crystal deposition in animal studies10 but, to date, no human studies have been possible and therefore this hypothesis remains untested. Key learning points: The Milwaukee shoulder tends to come on insidiously, typically over months or years and is often preceded by trauma or jointoveruse.Examinationreflectsrotator cuff losswithlargejointeffusions and humeral head subluxation. Synovial fluid alizarin red staining can be used to confirm the diagnosis and plain films are sufficient imaging and often depict significant humeral head subluxation as well as soft tissue calcification. We would like to highlight that as the syndrome often develops insidiously and the plain radiograph appearance is dramatic, the Milwaukee shoulder can easily be mistaken for other serious pathology, suchasatraumaticsubluxation,haemarthrosisorsepsis;howevertheclinical picture is characteristic allowing for a diagnosis based on clinical assessment and radiographs. This well documented but rare syndrome is animportantdifferentialdiagnosisofshoulderdiseasepresentingacutely.
USE OF DUAL ENERGY CT (DECT) SCAN TO ESTABLISH DIAGNOSIS OF GOUT IN DIALYSIS DEPENDENT PATIENT SUSPENDED FROM RENAL TRANSPLANT LIST DUE TO RECURRENT PYREXIAS OF UNKNOWN ORIGIN
Dr Iona Thorne, Imperial College Healthcare NHS Trust, London Introduction: This case highlights the emerging role that dual energy CT (DECT) scan can have in establishing the diagnosis of gout, where other other diagnostic tests have not been able to. We report using the DECT to establish the diagnosis of gout as cause of pyrexia of unknown origin in a dialysis patient who had been suspended from listing for renal transplantation until adiagnosis had been confirmed. Case description: A 63 year old male diaylsis patient was being investigated for pyrexia of unknown origin. He had a history of recurrent joint effusions,andanempiricaldiagnosisofgouthadbeenmadetwentyyears previously. The symptoms were classical for gout but the diagnosis had never been confirmed radiographically or on polarising microscopy. Urate level was elevated prior to commencing dialysis (>600 umol/L) but had fallen with dialysis, and ranged between 250-400 umol/L. He had been on low dose Allopurinol (maximum 200mg daily) for over 20 years and had been unable to continue with a trial of Febuxostat due to i20 11-12 October 2017 POSTER CASE REPORTS
